Regional therapy trials in peritoneal metastases: The path to standardization-Colorectal cancer

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska, USA.
² Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.

Editorial

Jason M Foster et al. J Surg Oncol. 2022 Jan.

. 2022 Jan;125(1):57-63.

doi: 10.1002/jso.26740.

¹ Division of Surgical Oncology, Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska, USA.
² Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.

No abstract available

Keywords: CRS/HIPEC; colorectal cancer; peritoneal metastases; treatment; trials.

References

1. Huff T, Brand E. Pseudomyxoma peritoneii: treatment with the argon beam coagulator. Obstet Gynecol. 1992;80(3 Pt 2):569-571.
1. Eisenkop SM, Nalick RH, Wang HJ, Teng NN. Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival. Gynecol Oncol. 1993;51(2):224-229.
1. Sugarbaker PH. Dissection by electrocautery with a ball tip. J Surg Oncol. 1994;56(4):246-248.
1. Kraemer B, Scharpf M, Keckstein S, et al. A prospective randomized experimental study to investigate the peritoneal adhesion formation after waterjet injection and argon plasma coagulation (HybridAPC) in a rat model. Arch Gynecol Obstet. 2018;297(4):961-967.
1. Prodromidou A, Pandraklakis A, Iavazzo C. The emerging role of neutral argon plasma (PlasmaJet) in the treatment of advanced stage ovarian cancer: a systematic review. Surg Innov. 2020;27(3):299-306.